Teva nears deal for Allergan's generic drugs unit: source

Teva Pharmaceutical Industries Ltd (TEVA.TA) is in advanced talks to buy Allergan Plc's (AGN.N) generic drug business following a thus far unsuccessful effort to acquire peer Mylan NV (MYL.O), according to a person familiar with the matter.

Read Full Article

Teva plans to raise Mylan bid by as much as $2 billion: Bloomberg

Teva Pharmaceutical Industries Ltd (TEVA.TA) is preparing to raise its bid for rival drugmaker Mylan NV (MYL.O) by as much as $2 billion, to $43 billion, Bloomberg reported on Monday, citing people familiar with the matter.

Read Full Article

Mylan says Teva offer too low; criticizes stock, growth prospects

Mylan NV (MYL.O) rejected Teva Pharmaceutical Industries Ltd's (TEVA.TA) $40 billion takeover offer on Monday, saying in a scathing letter that it grossly undervalued the company and that Mylan has no interest in payment in what it termed "high-risk" Teva stock.

Read Full Article

Shire, Teva Pharmaceutical Settle Patent on Intuniv

Shire Plc (SHP) pulled off a settlement agreement with Teva Pharmaceutical Industries Ltd. (TEVA), enabling the later to manufacture cheap generic copies of Intuniv.

Read Full Article

Subscribe to VCpost newsletter

Sign up for our Deals of the Day newsletter.
We will not spam you!

Real Time Analytics